1-2 of 2
Hayley Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo

Hayley Ma, Bao Nguyen, Li Li, Sarah Greenblatt, Allen Williams, Ming Zhao, Mark Levis, Michelle Rudek, Amy Duffield, Donald Small
Journal: Blood
Blood (2014) 123 (10): 1525–1534.
https://doi.org/10.1182/blood-2013-08-523035
Published: 2014
Includes: Supplemental data
Journal Articles

Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants

Allison Galanis, Hayley Ma, Trivikram Rajkhowa, Abhijit Ramachandran, Donald Small, Jorge Cortes, Mark Levis
Journal: Blood
Blood (2014) 123 (1): 94–100.
https://doi.org/10.1182/blood-2013-10-529313
Published: 2014
Includes: Supplemental data